Researchers

no image

TOYODA Shingo
Lecturer in Medical School
Faculty Department of Medicine
Researchmap https://researchmap.jp/shingo.t.0201

Research Activities

Published Papers

  1. Development of a Prognostic Model for Patients Aged ≤65 Years With Metastatic Renal Cell Carcinoma.
    Yuya Oishi; Yuto Matsushita; Shinya Watanabe; Kyohei Watanabe; Hiromitsu Watanabe; Keita Tamura; Daisuke Motoyama; Takafumi Yanagisawa; Keiichiro Mori; Seitetsu Sugiyama; Kensuke Bekku; Shingo Toyoda; Takuhisa Nukaya; Ryoichi Maenosono; Kazumasa Komura; Motoo Araki; Kazutoshi Fujita; Kiyoshi Takahara; Haruhito Azuma; Teruo Inamoto
    Anticancer research  46  (6)  , 3293-3302, Jun. 2026 
  2. The Prognostic Significance of Radiographic Progression Without PSA Progression in Patients With Metastatic Hormone-Sensitive Prostate Cancer Treated With First-Line ARPI Therapy.
    Takeshi Tsutsumi; Shogo Yamazaki; Takuya Matsuda; Takuya Tsujino; Taizo Uchimoto; Takafumi Yanagisawa; Keiichiro Mori; Wataru Fukuokaya; Fumihiko Urabe; Masanobu Saruta; Atsuhiko Yoshizawa; Shingo Toyoda; Saizo Fujimoto; Kyosuke Nishio; Moritoshi Sakamoto; Tatsuo Fukushima; Ko Nakamura; Kazuki Nishimura; Keita Nakamori; Tomohisa Matsunaga; Yuki Yoshikawa; Ryoichi Maenosono; Kiyoshi Takahara; Teruo Inamoto; Takahiro Kimura; Kazutoshi Fujita; Kazumasa Komura; Haruhito Azuma
    The Prostate  86  (8)  , 882-890, Jun. 2026 
  3. Development of a prognostic model for elderly patients with metastatic clear cell renal cell carcinoma treated with first-line immuno-oncology combination therapy.
    Shinya Watanabe; Yuto Matsushita; Yuya Oishi; Kyohei Watanabe; Hiromitsu Watanabe; Keita Tamura; Daisuke Motoyama; Takafumi Yanagisawa; Keiichiro Mori; Seitetsu Sugiyama; Kensuke Bekku; Lan Inoki; Shingo Toyoda; Takuhisa Nukaya; Ryoichi Maenosono; Kazumasa Komura; Motoo Araki; Kazutoshi Fujita; Kiyoshi Takahara; Haruhito Azuma; Toshiki Ito; Teruo Inamoto
    Japanese journal of clinical oncology  17, May. 2026 

MORE

MISC

  1. DEVELOPMENT OF PROGNOSTIC MODEL INCORPORATING TUMOR BURDEN IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA: RESULTS OF A MULTICENTER COHORT STUDY , Hirokazu Kagawa; Wataru Fukuokaya; Takafumi Yanagisawa; Tatsushi Kawada; Satoshi Katayama; Takuya Tsujino; Ryoichi Maenosono; Shingo Toyoda; Takuhisa Nukaya; Hirofumi Morinaka; Keita Tamura; Fumihiko Urabe; Keiichiro Mori; Masaya Murakami; Kensuke Bekku; Kiyoshi Takahara; Kazutoshi Fujita; Haruhito Azuma; Motoo Araki; Kazumasa Komura; Teruo Inamoto; Takahiro Kimura , JOURNAL OF UROLOGY , 215 , 5S , May. 2026
  2. NIVOLUMAB PLUS CABOZANTINIB VERSUS PEMBROLIZUMAB PLUS LENVATINIB FOR METASTATIC RENAL CELL CARCINOMA: A PROPENSITY SCORE-MATCHED ANALYSIS OF JAPANESE MULTICENTER DATABASE , Takafumi Yanagisawa; Keiichiro Mori; Tatsushi Kawada; Satoshi Katayama; Takuya Tsujino; Ryoichi Maenosono; Shingo Toyoda; Takuhisa Nukaya; Hirofumi Morinaka; Keita Tamura; Wataru Fukuokaya; Fumihiko Urabe; Masaya Murakami; Kensuke Bekku; Kiyoshi Takahara; Kazutoshi Fujita; Haruhito Azuma; Motoo Araki; Kazumasa Komura; Teruo Inamoto; Takahiro Kimura , JOURNAL OF UROLOGY , 215 , 5S , May. 2026
  3. 免疫組織学的染色により転移性去勢感受性前立腺癌の予後を予測する , 西本光寿; 西本光寿; デベラスコ マルコ; 山本豊; 藤本西蔵; 明石泰典; 豊田信吾; 橋本士; 南高文; 平山暁秀; 吉村一宏; 藤田和利 , 泌尿器科分子・細胞研究会プログラム・抄録集 , 34th , 2025

MORE